<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35370531</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1613-5636</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>3</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Der Pneumologe</Title><ISOAbbreviation>Pneumologe (Berl)</ISOAbbreviation></Journal><ArticleTitle>[Outpatient pulmonary rehabilitation].</ArticleTitle><Pagination><StartPage>150</StartPage><EndPage>157</EndPage><MedlinePgn>150-157</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10405-022-00442-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Outpatient pulmonary rehabilitation (PR) plays a&#xa0;central role in the integrative care of patients with pulmonary diseases.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="UNASSIGNED">The article gives an overview of the recent evidence on outpatient PR in various diseases, in various settings including the cost-effectiveness. This is based on a&#xa0;selective literature search in the PubMed and Medline databanks, current expert opinions and clinical experiences.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Early rehabilitation after exacerbation in COPD patients leads to a reduction of rehospitalizations (hazard ratio 0.83) and to a reduction of mortality (hazard ratio 0.63) over a period of 12&#xa0;months. Telerehabilitation is a&#xa0;promising future perspective in specific settings. Recent publications on bronchiectasis, interstitial lung diseases and pulmonary hypertension could confirm the safety and feasibility of outpatient PR and the cost-effectiveness could be demonstrated. Also, the evidence for inpatient as well as outpatient PR settings for patients with post-COVID and long COVID is growing.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">There is growing equivalence with respect to the evidence on PR, independent of whether it is carried out in an outpatient or inpatient setting.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zwick</LastName><ForeName>Ralf Harun</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Therme Wien Med, Ludwig Boltzmann Institut f&#xfc;r Rehabilitationsforschung, Kurbadstr.&#xa0;14, 1100 Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Ambulante pneumologische Rehabilitation.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Pneumologe (Berl)</MedlineTA><NlmUniqueID>101233663</NlmUniqueID><ISSNLinking>1613-5636</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="HINTERGRUND">Ambulante pneumologische Rehabilitation (PR) spielt eine zentrale Rolle in der integrativen Versorgung von Patient:innen mit Lungenerkrankungen.</AbstractText><AbstractText Label="MATERIAL UND METHODE">In dieser Arbeit wird die rezente Evidenz zu ambulanter PR bei verschiedenen Erkrankungen, in verschiedenen Settings inklusive der Kosteneffektivit&#xe4;t dargelegt. Diese basiert auf Literaturrecherche in den Datenbanken PubMed und MEDLINE, aktuellen Expertenmeinungen und klinischen Erfahrungen.</AbstractText><AbstractText Label="ERGEBNISSE">Fr&#xfc;he Rehabilitation nach Exazerbation f&#xfc;hrt bei COPD(chronisch obstruktive Lungenerkrankung)-Patient:innen zu einer Reduktion der Wiederaufnahme im Spital (Hazard Ratio 0,83) und zu einer Reduktion der Mortalit&#xe4;t (Hazard Ratio 0,63) &#xfc;ber den Zeitraum von 12&#xa0;Monaten. Telerehabilitation ist eine vielversprechende Zukunftsperspektive in spezifischen Settings. Rezente Publikationen zu Bronchiektasenerkrankungen, interstitiellen Lungenerkrankungen und pulmonaler Hypertonie konnten die Machbarkeit und Sicherheit der ambulanten PR best&#xe4;tigen, und die Kosteneffektivit&#xe4;t konnte dargestellt werden. Auch zu Post&#x2011;/Long-COVID mehrt sich die Evidenz im station&#xe4;ren wie im ambulanten Reha-Setting.</AbstractText><AbstractText Label="SCHLUSSFOLGERUNGEN">Es besteht zunehmend eine Gleichwertigkeit in Bezug auf die Evidenz der PR &#x2013; unabh&#xe4;ngig davon, ob sie im ambulanten oder station&#xe4;ren Setting erfolgt.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic obstructive pulmonary disease</Keyword><Keyword MajorTopicYN="N">Cost-effectiveness</Keyword><Keyword MajorTopicYN="N">Interstitial lung diseases</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Telerehabilitation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>4</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35370531</ArticleId><ArticleId IdType="pmc">PMC8953964</ArticleId><ArticleId IdType="doi">10.1007/s10405-022-00442-4</ArticleId><ArticleId IdType="pii">442</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Spruit MA, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in&#xa0;pulmonary&#xa0;rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13&#x2013;e64. doi: 10.1164/rccm.201309-1634ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201309-1634ST</ArticleId><ArticleId IdType="pubmed">24127811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenauer PK, et al. Association between initiation of pulmonary rehabilitation after hospitalization for COPD and 1-year survival among medicare beneficiaries. JAMA. 2020;323:1813&#x2013;1823. doi: 10.1001/jama.2020.4437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4437</ArticleId><ArticleId IdType="pmc">PMC7218499</ArticleId><ArticleId IdType="pubmed">32396181</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan MA, et al. Association between initiation of pulmonary rehabilitation and rehospitalizations in patients hospitalized with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021 doi: 10.1164/rccm.202012-4389OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202012-4389OC</ArticleId><ArticleId IdType="pmc">PMC8663014</ArticleId><ArticleId IdType="pubmed">34283694</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox NS, et al. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev. 2021;1:CD013040. doi: 10.1002/14651858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858</ArticleId><ArticleId IdType="pmc">PMC8095032</ArticleId><ArticleId IdType="pubmed">33511633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AL, et al. Exercise training for bronchiectasis. Cochrane Database Syst Rev. 2021;4(4):CD013110. doi: 10.1002/14651858.CD013110.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013110.pub2</ArticleId><ArticleId IdType="pmc">PMC8093919</ArticleId><ArticleId IdType="pubmed">33822364</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowman L, et al. Pulmonary rehabilitation for&#xa0;interstitial&#xa0;lung&#xa0;disease. Cochrane Database Syst Rev. 2021;2(2):CD006322. doi: 10.1002/14651858.CD006322.pub4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006322.pub4</ArticleId><ArticleId IdType="pmc">PMC8094410</ArticleId><ArticleId IdType="pubmed">34559419</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L, et al. The benefit of exercise-based rehabilitation programs in patients with pulmonary hypertension: a&#xa0;systematic review and meta-analysis of randomized controlled trials. Pulm Circ. 2021;11(2):20458940211007810. doi: 10.1177/20458940211007810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20458940211007810</ArticleId><ArticleId IdType="pmc">PMC8165522</ArticleId><ArticleId IdType="pubmed">34104422</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R, et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res. 2021;7(2):00108-2021. doi: 10.1183/23120541.00108-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00108-2021</ArticleId><ArticleId IdType="pmc">PMC7957293</ArticleId><ArticleId IdType="pubmed">34095290</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, Moik F, Klok FA, Gattinger D, Petrovic M, Vonbank K, Koczulla AR, Ay C, Zwick RH. Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life. Respiration. 2022 doi: 10.1159/000522118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisaccia G, et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: What do we know? J Cardiovasc Dev Dis. 2021;8(11):156. doi: 10.3390/jcdd8110156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd8110156</ArticleId><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabady S, et al. Guideline S1: long covid. Diagnostics and treatment strategies. Wien Klin Wochenschr. 2021;133(Suppl 7):237&#x2013;278. doi: 10.1007/s00508-021-01974-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-021-01974-0</ArticleId><ArticleId IdType="pmc">PMC8633909</ArticleId><ArticleId IdType="pubmed">34851455</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>